Concepedia

Wei Fu

WF

Statistics

Publications

8

Citations

181

H-Index

8

Active since

2006

Affiliations

GlaxoSmithKline (United States)(Current)

Second Affiliated Hospital of Nanchang University

Nanchang University

Wei Fu is an author at GlaxoSmithKline (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

2006–2023

8

Publications

8

RETRACTED ARTICLE: Extracellular vesicles derived from HBMSCs improved myocardial infarction through inhibiting zinc finger antisense 1 and activating Akt/Nrf2/HO-1 pathway

Huiling Xiao, Dan Wu, Tao Yang et al. · Bioengineered · 2022 · 34 citations · Full text

3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonists

Yonghui Wang, Jakob Busch‐Petersen, Feng Wang et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 30 citations · Full text

, , +5

N,N′-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors

Hong Nie, Katherine L. Widdowson, Michael R. Palovich et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 24 citations · Full text

, , +8

Tectorigenin relieved sepsis-induced myocardial ferroptosis by inhibiting the expression of Smad3

Xiaowei Fang, Wei Fu, Bing Zou et al. · Toxicology Research · 2023 · 22 citations · Full text

Neogambogic acid relieves myocardial injury induced by sepsis <i>via</i> p38 MAPK/NF-κB pathway

Wei Fu, Xiaowei Fang, Lidong Wu et al. · Korean Journal of Physiology and Pharmacology · 2022 · 20 citations · Full text

, , +16

1–5 of 8